Core Viewpoint - Cameco Corporation is a leading uranium producer with strong financial performance and significant institutional interest, indicating a positive outlook for the company. Financial Performance - Cameco reported earnings per share (EPS) of $0.36 for the last quarter, exceeding analysts' expectations of $0.29 by $0.07 [2] - The company's revenue for the quarter was $874.57 million, surpassing analyst estimates of $782.13 million, reflecting a year-over-year revenue increase of 1.5% [2] - Cameco's net margin stands at 17.00% and return on equity is at 9.35% [2] - The company has a market capitalization of $51.89 billion, a PE ratio of 122.83, and a beta of 0.99 [1] Stock Performance - Shares of Cameco opened at $119.14, with a 52-week low of $35.00 and a high of $135.24 [1] - The stock's 50-day moving average price is $108.19, and the 200-day moving average price is $92.95 [1] Institutional Trading - Institutional investors own 70.21% of Cameco's stock, indicating strong institutional confidence [3][4] - Abbington Investment Group purchased a new position worth $6.51 million in the third quarter [3] - Mirae Asset Global Investments increased its holdings by 79.4%, now owning shares valued at $20.96 million [3] - Hillsdale Investment Management raised its position by 165.1%, acquiring shares worth $12.59 million [3] Analyst Ratings - National Bank Financial and Raymond James Financial both maintain an "outperform" rating for Cameco [5] - Royal Bank of Canada raised its target price for Cameco from $150.00 to $160.00 [5] - Zacks Research upgraded Cameco from a "hold" to a "strong-buy" rating [5] - The consensus rating for Cameco is "Buy" with an average target price of $143.03 [5] Company Overview - Cameco Corporation is a major player in the uranium production sector, supplying the global nuclear power industry [7] - The company is involved in the exploration, mining, milling, and sale of uranium concentrate, known as yellowcake, which is essential for nuclear reactors [7] - Cameco's operations are primarily based in Canada and the United States [8]